tiprankstipranks
TransMedics Group Inc (TMDX)
NASDAQ:TMDX
US Market

TransMedics Group (TMDX) Income Statement

Compare
1,301 Followers

TransMedics Group Income Statement

Last quarter (Q3 2024), TransMedics Group's total revenue was $108.76M, an increase of 63.72% from the same quarter last year. In Q3, TransMedics Group's net income was $4.22M. See TransMedics Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 241.62M$ 93.46M$ 30.26M$ 25.64M$ 23.60M
Gross Profit
$ 154.09M$ 65.27M$ 21.16M$ 16.64M$ 13.86M
Operating Expenses
$ 182.82M$ 96.71M$ 60.59M$ 43.02M$ 43.47M
Depreciation and Amortization
$ 8.18M$ 4.20M$ 2.65M$ 1.58M$ 1.22M
EBITDA
$ -7.60M$ -28.96M$ -38.49M$ -23.15M$ -27.93M
Operating Income
$ -28.73M$ -31.44M$ -39.43M$ -26.38M$ -29.60M
Other Income/Expenses
$ 2.06M$ -4.73M$ -4.75M$ -2.33M$ -3.90M
Pretax Income
$ -26.67M$ -36.16M$ -44.18M$ -28.72M$ -33.51M
Net Income
$ -25.03M$ -36.23M$ -44.22M$ -28.75M$ -33.55M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.77$ -1.23$ -1.60$ -1.16$ -2.36
Diluted EPS
$ -0.77$ -1.23$ -1.60$ -1.16$ -2.36
Weighted Average Shares Outstanding
32.52M 29.56M 27.62M 24.70M 14.20M
Weighted Average Shares Outstanding (Diluted)
32.52M 29.56M 27.62M 24.70M 14.20M
Currency in USD

TransMedics Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis